Bo-cheng Huang

No 100 Shih Chuan 1st Road
Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy.

Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy.

Journal: International journal of biological macromolecules

Published: February 26, 2026

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.

Journal: International journal of biological macromolecules

Published: October 27, 2025

Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue.

Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue.

Journal: Journal of translational medicine

Published: September 14, 2025

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.

Journal: NPJ vaccines

Published: May 28, 2025

Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.

Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy.

Journal: International journal of biological macromolecules

Published: February 17, 2025

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Journal: International journal of biological macromolecules

Published: October 12, 2024

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Journal: International journal of biological macromolecules

Published: September 20, 2024

Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer.

Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer.

Journal: International journal of biological macromolecules

Published: September 05, 2024

Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety.

Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety.

Journal: International journal of biological macromolecules

Published: August 29, 2024

Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.

Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.

Journal: Biomaterials research

Published: August 07, 2024

Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab.

Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab.

Journal: International journal of biological macromolecules

Published: September 20, 2023

Structural insights into Nirmatrelvir (PF-07321332)-3C-like SARS-CoV-2 protease complexation: a ligand Gaussian accelerated molecular dynamics study.

Structural insights into Nirmatrelvir (PF-07321332)-3C-like SARS-CoV-2 protease complexation: a ligand Gaussian accelerated molecular dynamics study.

Journal: Physical chemistry chemical physics : PCCP

Published: September 20, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026